Triple Threat

(8 customer reviews)


or 4 interest-free payments of $13.75 with 
For a limited time, BUY ONE GET ONE FREE!
Get DOUBLE your order for the price above.
Must use SEZZLE at checkout.

In stock

▪ Wet Mass Gains
▪ Lean Bulking
▪ Low Estrogen Conversion
▪ Increase Strength and Libido

Triple Threat is the latest formulation from UnNaturals Labs. Triple Threat is a potent blend of 3 anabolic compounds including Androsterone, 1-Andro, and 4-Andro.

Triple threat does require post cycle therapy (Beast) and should not be used longer than 2 months without a break. 

Instructions: As a dietary supplement take 2 (two) capsules daily preferably 1 (one) in the morning and 1 (one) in the evening. Do not exceed 2 (two) capsules in a 24-hour period.


  • Androsterone – Converts to DHT, the male sex hormone. Helps increase strength and libido
  • 1-Andro – Converts to 1-Testosterone. Considered a lean bulking compound, 1-Andro is the premiere legal anabolic compound on the market and will allow you to build strength and size without excess water weight.
  • 4-Andro – Converts to Testosterone. Considered a “wet” gainer, 4-Andro will help you build strength and size, but does aromatize which may result in excess water retention. 4-Andro is great for libido.

8 reviews for Triple Threat

  1. Aaron B. (verified owner)

    Incredible product, can definitely feel it already!

  2. Asael (verified owner)

    This one I just want to keep taking it,but I have to follow the cycle!!!!!

  3. Anonymous (verified owner)

  4. Matheus Campos (verified owner)

  5. Jonathan L. (verified owner)

    Works great, feels safe, and worth the money.

    1 product
  6. Ralph S. (verified owner)

    Really fast delivery. So far so good with the product. Already seeing results.

    1 product
  7. Waylon G. (verified owner)

    Almost no workout fatigue. Acts quickly. Steady energy.

    1 product
  8. Hector K. (verified owner)

    This product is the bomb! It is amazing

    1 product
Add a review

Your email address will not be published. Required fields are marked *


Go to Top